artemether has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Han, P; Shao, M; Sun, H; Wang, T; Weng, W; Yu, X | 1 |
| Antunes, LR; Grabe-Guimarães, A; Guimarães, HN; Mosqueira, VCF; Richard, S; Silveira, APA; Souza, ACM | 1 |
2 other study(ies) available for artemether and Cardiotoxicity
| Article | Year |
|---|---|
Artemether ameliorates adriamycin induced cardiac atrophy in mice.
Topics: Animals; Artemether; Atrophy; Cardiotoxicity; Doxorubicin; Hydrogen Peroxide; Mice; Myocytes, Cardiac | 2023 |
Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice.
Topics: Administration, Oral; Animals; Antimalarials; Artemether; Cardiotoxicity; Disease Models, Animal; Electrocardiography; Female; Malaria; Male; Mice; Mice, Inbred C57BL; Nanocapsules; Plasmodium berghei | 2018 |